NCT03388281

Brief Summary

Previous publications suggest gender difference in outcome parameters after pacemaker implantation. Aim of this study is to investigate gender differences in patients with pacemaker. Implanted devices, indication for implantation and pacemaker follow up data of patients will be included. Survival data including cause of death will be documented. Prevalent comorbidities and relevant laboratory data will be recorded.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11,444

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2015

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 28, 2015

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2016

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

December 22, 2017

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 2, 2018

Completed
Last Updated

January 2, 2018

Status Verified

December 1, 2017

Enrollment Period

8 months

First QC Date

December 22, 2017

Last Update Submit

December 29, 2017

Conditions

Keywords

PacemakerGender differencesSurvivalRetrospective

Outcome Measures

Primary Outcomes (1)

  • Survival after pacemaker implantation

    Null hypothesis: There is no survival difference between women and men after pacemaker Implantation.

    10 years

Secondary Outcomes (2)

  • Implantation rates of single- or dual-chamber Pacemaker in women/men.

    Data obtained: April 30th, 2015

  • Survival of women/men after single- or dual-chamber pacemaker implantation.

    10 years

Other Outcomes (6)

  • First implantation age in single- or dual-chamber pacemaker

    Data obtained: April 30th, 2015

  • Time to device- or lead-replacement

    10 years

  • Prevalence of Comorbidities

    Survival analysis: 10 years; data obtained: March 2nd, 2016

  • +3 more other outcomes

Study Arms (1)

Patients with implanted pacemaker

Patients with implanted cardiac pacemaker registered in pacemaker database of the Department of Cardiology at the Medical University Vienna were included.

Other: No intervention, retrospective analysis only.

Interventions

No intervention, retrospective analysis only.

Patients with implanted pacemaker

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women and men with implanted cardiac Pacemaker and at least one follow up in our Pacemaker Office of the Department of Cardiology at the Medical University Vienna. Patients were enrolled regardless of time and place of pacemaker implantations.

You may qualify if:

  • All patients registered in the pacemaker database of the Department of Cardiology at the Medical University Vienna. Patients get registered when clinical follow up of an implanted Pacemaker is done.

You may not qualify if:

  • For survival analysis: No valid match of first name AND surname AND date of birth with patients' insurance data.
  • For analysis of comorbidities: Not a single documented diagnose was found in our electronic clinic-wide patients' information system.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Riesenhuber M, Spannbauer A, Rauscha F, Schmidinger H, Boszotta A, Pezawas T, Schukro C, Gwechenberger M, Stix G, Anvari A, Wrba T, Khazen C, Andreas M, Laufer G, Hengstenberg C, Gyongyosi M. Sex Differences and Long-Term Outcome in Patients With Pacemakers. Front Cardiovasc Med. 2020 Sep 22;7:569060. doi: 10.3389/fcvm.2020.569060. eCollection 2020.

Study Officials

  • Mariann Gyöngyösi, MD, PhD

    Medical University of Vienna

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Cardiologist, Assoc. Prof. Univ.-Doz. Dr.

Study Record Dates

First Submitted

December 22, 2017

First Posted

January 2, 2018

Study Start

July 28, 2015

Primary Completion

March 31, 2016

Study Completion

March 31, 2016

Last Updated

January 2, 2018

Record last verified: 2017-12

Data Sharing

IPD Sharing
Will share

Sharing of IPD is planned.